Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DR26FQP4M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,492
Award facts
- Contract value 100% obligated
- $19,491.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,491.96 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on November 5, 2025, with completion targeted for November 28, 2025. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
Benlysta (belimumab) is a biologic immunosuppressant medication used primarily to treat systemic lupus erythematosus and other autoimmune conditions, making this delivery order part of AmerisourceBergen's comprehensive pharmaceutical supply portfolio to the federal government. The company's DLA contract vehicle enables it to supply a broad spectrum of pharmaceutical products, medical devices, vaccines, and specialty medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. As a non-set-aside award, this delivery order reflects AmerisourceBergen's competitive capability and established position within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQP4M?
SPE2DR26FQP4M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FQP4M worth?
The government has obligated $19,492 on SPE2DR26FQP4M.
Is contract SPE2DR26FQP4M an order under another contract?
Yes. SPE2DR26FQP4M is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP4M competed?
The extent of competition for SPE2DR26FQP4M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award